Bavencio and Polymyalgia rheumatica aggravated - a phase IV clinical study of FDA data

Summary:

Polymyalgia rheumatica aggravated is reported as a side effect among people who take Bavencio (avelumab), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Inlyta, and have Renal cell carcinoma.

The phase IV clinical study analyzes which people have Polymyalgia rheumatica aggravated when taking Bavencio. It is created by eHealthMe based on reports of 1,606 people who have side effects when taking Bavencio from the FDA, and is updated regularly.

What is Bavencio?

Bavencio has active ingredients of avelumab. eHealthMe is studying from 1,606 Bavencio users. Check the latest studies of Bavencio.

What is Polymyalgia rheumatica aggravated?

Polymyalgia rheumatica aggravated (serious pain in many muscles) is found to be associated with 377 drugs and 334 conditions by eHealthMe. Check the latest studies of Polymyalgia rheumatica aggravated.

On Jul, 14, 2026

1,606 people reported to have side effects when taking Bavencio.
Among them, 13 people (0.81%) have Polymyalgia rheumatica aggravated.

Could Bavencio cause Polymyalgia rheumatica aggravated?

Among these 13 people:

How long have people been on Bavencio when they have Polymyalgia rheumatica aggravated? *

What is the gender of people who have Polymyalgia rheumatica aggravated when taking Bavencio? *

female: 0.0 %
male: 100 %

What is the age of people who have Polymyalgia rheumatica aggravated when taking Bavencio? *

What are other drugs people take besides Bavencio? *

Inlyta: 8 people, 61.54%
Tamsulosin: 4 people, 30.77%
Simvastatin: 4 people, 30.77%
Losartan: 4 people, 30.77%
Amlodipine Besylate: 4 people, 30.77%

What are other side effects people have besides Polymyalgia rheumatica aggravated? *

Fatigue (feeling of tiredness): 2 people, 15.38%

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 8 people, 61.54%
Neuroendocrine Carcinoma Of The Skin (a rare type of cancer that forms on or just beneath the skin, usually in parts of the body that have been exposed to the sun): 4 people, 30.77%
High Blood Pressure: 2 people, 15.38%
High Blood Cholesterol: 2 people, 15.38%
Enlarged Prostate: 2 people, 15.38%
Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Bavencio and have Polymyalgia rheumatica aggravated?

- Check whether Polymyalgia rheumatica aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bavencio:

Bavencio (1,606 reports)

Browse all side effects of Bavencio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Polymyalgia rheumatica aggravated:

Polymyalgia rheumatica aggravated (377 drugs)

Browse all the conditions that are associated with Polymyalgia rheumatica aggravated:

Polymyalgia rheumatica aggravated (334 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on avelumab (the active ingredients of Bavencio) and Bavencio (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.